Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer
Table 4
The target genes that inferred from CLIP-Seq, RIP-Seq, CHIP-Seq, or mass spectrometry.
Binding
Species
Cell line
Class
WER name
Target gene
Interaction
Method
Downstream effect
Human
HeLa
Writer
VIRMA
LMAN2
Protein-protein
Mass spectrometry
Methylation
Human
HEK293T
Reader
IGF2BP1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
IGF2BP3
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
YTHDC1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
YTHDF1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HeLa
Writer
VIRMA
LMAN2
Protein-protein
Mass spectrometry
Methylation
Human
HEK293T
Reader
IGF2BP1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
IGF2BP3
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
YTHDC1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HEK293T
Reader
YTHDF1
LMAN2
Protein-RNA
CLIP-Seq
No evidence
Human
HeLa
Writer
VIRMA
LMAN2
Protein-protein
Mass spectrometry
Methylation
WERs: writers, erasers, and readers. “Protein-RNA” represents the genes inferred from various kinds of CLIP-Seq or RIP-Seq. “Protein-DNA” refers to the CHIP-Seq results, while “protein-protein” means targets summarized from mass spectroscopy results.